Evidence map›Paper›PMID 33560997›Full record

ArticleJMIR public health and surveillance2021

With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines.

Zhaohui Su, Dean McDonnell, Ali Cheshmehzangi, Xiaoshan Li, Daniel Maestro, Sabina Šegalo, Junaid Ahmad, Xiaoning Hao

Open access · goldAbstract read
In one paragraph

Article in JMIR public health and surveillance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Mind the "Vaccine Fatigue".Frontiers in immunology · 2022
    Review
  9. Article
  10. Rigorous Policy-Making Amid COVID-19 and Beyond: Literature Review and Critical Insights.International journal of environmental research and public health · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 6 countries.

Zhaohui SuCenter on Smart and Connected Health Technologies, Mays Cancer Center, School of Nursing, UT Health San Antonio, San Antonio, TX, United States.ORCID 0000-0003-2005-9504
Dean McDonnellDepartment of Humanities, Institute of Technology Carlow, Carlow, Ireland.ORCID 0000-0001-6043-8272
Ali CheshmehzangiDepartment of Architecture and Built Environment, University of Nottingham Ningbo China, Ningbo, China.ORCID 0000-0003-2657-4865
Xiaoshan LiProgram of Public Relations and Advertising, Beijing Normal University-Hong Kong Baptist University United International College, Zhuhai, China.ORCID 0000-0002-1765-4815
Daniel MaestroDepartment of Environmental Health, Institute for Public Health of Federation Bosnia and Herzegovina, Sarajevo, Bosnia and Herzegovina.ORCID 0000-0002-3830-8671
Sabina ŠegaloDepartment of Microbiology, Faculty of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.ORCID 0000-0002-9280-3278
Junaid AhmadPrime Institute of Public Health, Peshawar Medical College, Peshawar, Pakistan.ORCID 0000-0002-8580-7529
Xiaoning HaoDivision of Health Security Research, China National Health Development Research Center, National Health Commission, P.R. China, Beijing, China.ORCID 0000-0002-1111-5626
Beijing Normal-Hong Kong Baptist University · CNChina National Health Development Research Center · CNHiroshima University · JPInstitute of Technology Carlow · IEPublic Health Institute of the Republic of Srpska · BAThe University of Texas Health Science Center at San Antonio · USUniversity of Sarajevo · BA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although COVID-19 vaccines are becoming increasingly available, their ability to effectively control and contain the spread of the COVID-19 pandemic is highly contingent on an array of factors. This paper discusses how limitations to vaccine accessibility, issues associated with vaccine side effects, concerns regarding vaccine efficacy, along with the persistent prevalence of vaccine hesitancy among the public, including health care professionals, might impact the potential of COVID-19 vaccines to curb the pandemic. We draw insights from the literature to identify practical solutions that could boost people's adoption of COVID-19 vaccines and their accessibility. We conclude with a discussion on health experts' and government officials' moral and ethical responsibilities to the public, even in light of the urgency to adopt and endorse "the greatest amount of good for the greatest number" utilitarian philosophy in controlling and managing the spread of COVID-19.

Indexed as

COVID-19COVID-19 VaccinesHealth Services AccessibilityHopeHumansMotivationPandemicsVaccinationCOVID-19 VaccinesChinaconsequencecoronavirusCOVID-19COVID-19 vaccineefficacyexpectationinfectious diseasemade in Chinapublic healthsafetystandardvaccinevaccine efficacyvaccine safety

Identifiers

PMID33560997
PMCPMC8341090
OpenAlexW3128520153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.